ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 800,85
1,47%
DAX
18 518,03
-0,44%
Brent Oil
83,35
-1,17%
Bitcoin
64 415,33
-0,67%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioPlus Acquisition Corporation (BIOS)

  7. BioPlus Acquisition Corporation (BIOS) Actualités

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateHeureSourceTitreSymboleSociété
31/03/201422h01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BIOSBioPlus Acquisition Corporation
03/03/201421h58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
26/02/201423h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
26/02/201423h03PR Newswire (US)BioScrip Reports Fourth Quarter 2013 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
18/02/201416h00ZacksHealthcare Boom Brings This Sector ETF in Focus - ETF News And CommentaryNASDAQ:BIOSBioPlus Acquisition Corporation
14/02/201418h06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
14/02/201412h03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSBioPlus Acquisition Corporation
13/02/201400h06Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BIOSBioPlus Acquisition Corporation
11/02/201423h00PR Newswire (US)BioScrip to Host Fourth Quarter and Year-end 2013 Earnings CallNASDAQ:BIOSBioPlus Acquisition Corporation
11/02/201422h30PR Newswire (US)BioScrip Closes Private Placement of $200 Million of 8.875% Senior Notes due 2021NASDAQ:BIOSBioPlus Acquisition Corporation
06/02/201423h00PR Newswire (US)BioScrip Announces Pricing of 8.875% Senior Notes Due 2021NASDAQ:BIOSBioPlus Acquisition Corporation
03/02/201423h00PR Newswire (US)LHC Group to acquire Deaconess HomeCareNASDAQ:BIOSBioPlus Acquisition Corporation
03/02/201413h16PR Newswire (US)BioScrip Announces Proposal to Commence Offering $200 Million of Senior NotesNASDAQ:BIOSBioPlus Acquisition Corporation
03/02/201413h15PR Newswire (US)BioScrip to Sell Home Health Services Business to LHC GroupNASDAQ:BIOSBioPlus Acquisition Corporation
14/01/201414h30PR Newswire (US)BioScrip Appoints Tricia Huong Thi Nguyen To Board Of DirectorsNASDAQ:BIOSBioPlus Acquisition Corporation
22/11/201322h14Business WireGlancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against BioScrip, Inc.NASDAQ:BIOSBioPlus Acquisition Corporation
22/11/201314h00PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against BioScrip, Inc. and Certain Officers - BIOSNASDAQ:BIOSBioPlus Acquisition Corporation
18/11/201317h02MarketwiredSaxena White P.A. Files Securities Fraud Class Action Against BioScrip, Inc.NASDAQ:BIOSBioPlus Acquisition Corporation
15/11/201316h51Business WireDEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of BioScrip, Inc. of Upcoming DeadlineNASDAQ:BIOSBioPlus Acquisition Corporation
12/11/201322h15Business WireBioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against BioScrip, Inc. & Its Board ...NASDAQ:BIOSBioPlus Acquisition Corporation
11/11/201321h46Business WireBioScrip Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor Investigate Possible Breaches of Fiduciary Dut...NASDAQ:BIOSBioPlus Acquisition Corporation
08/11/201323h18Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BIOSBioPlus Acquisition Corporation
08/11/201304h00Business WireBIOSCRIP SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Exce...NASDAQ:BIOSBioPlus Acquisition Corporation
07/11/201318h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIOSBioPlus Acquisition Corporation
06/11/201323h00PR Newswire (US)BioScrip Reports Third Quarter 2013 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
02/11/201302h00MarketwiredFaruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in BioScrip, Inc. to Contact th...NASDAQ:BIOSBioPlus Acquisition Corporation
25/10/201321h53MarketwiredSHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against BioScrip, Inc. and Certain Officers - BIOSNASDAQ:BIOSBioPlus Acquisition Corporation
21/10/201322h30PR Newswire (US)BioScrip To Host Third Quarter 2013 Earnings CallNASDAQ:BIOSBioPlus Acquisition Corporation
12/10/201302h30PR Newswire (US)Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In BioScrip, Inc. To Contact Th...NASDAQ:BIOSBioPlus Acquisition Corporation
09/10/201320h14PR Newswire (US)Lifshitz Law Firm Announces Investigation of Active Network, BioScrip, Inc., Edgen Group Inc., Flow International Corporation...NASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
RNO
Renault
EU
BNP
BNP Paribas
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
NASDAQ
AAPL
Apple
EU
BEL20
Bel 20
EU
PX1
CAC 40
FTSE
UKX
FTSE 100
EU
SGO
Cie de SaintGobain
COIN
ETHUSD
Ethereum
EU
PX4
SBF 120
NASDAQ
GOOGL
Alphabet
EU
RI
Pernod Ricard
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés